1National Cancer Institute Workshop.The 1988 Bethesda system for reporting cervical /vaginal diagnosis[J].JAMA,1989,262:931-934. 被引量：1
2Anonymous.The Bethesda system for reporting cervical /vaginal cytologic diagnoses:revised after the Second National Cancer Institute Workshop[J].Acta Cytol,1993,37:115-124. 被引量：1
3Jones HW.Clinical treatment of women with atypical squamous cells of undetermined significance or atypical glandular cells of undetermined significance cervical cytology[J].Clini Obstet Gynecol,2000,43:381-393. 被引量：1
4Ergeneli MH,Duran EH,Ergin TE,et al.Atypical squamous cells of undetermined significance:Clinical experience in a Turkish university hospital[J].Europ J Obstet Gynecol Reproduc Bio,2001,96:108-110. 被引量：1
5Cox JT.Management of women with cervical cytology interpreted as ASC-CU or as ASC-H[J].Clini Obstet gynecol,2005,48:160-170. 被引量：1
6Infantolino C,Fabris P,Infantolino D,et al.Usefulness of human papilloma virus testing in the screening of cervical cancer precursor lesion:a retropspective study in 314 cases[J].Europ J Obstet Gynecol Reproduc Bio,2000,93:71-75. 被引量：1
7Kobelin MH,Kobelin CG,Burke L,et al.Incidence and predictors of cervical dysplasia in patients with minimally abnormal papanicolaou smears[J].Obstet Gynecol,1998,92:356-359. 被引量：1
6Pahuja S,Choudhurg M,Gupta U.Ki-67 immunostaining in Pap smear of cervix:assessment of proliferation in preinvasive and invasive aquamous epithelial lesions[J].Indian Pathol Microbiol,2004,47(1):1-3. 被引量：1
7Ries L,Kosary C,Hanky B,et al.SEER cancer statistics review,1973-1995[C].Bethesda,MD:National Cancer Institute,1998. 被引量：1
8Remont-Smith M,Marino J,Greffin B,et al.Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study[J].Cancer,2004,102:269-279. 被引量：1
9Gerber S,Granddi PO,Petignat P,et al.Colposcopic evaluation after atypical aquzmous cell of undermined significance (ASCUS) smear[J].Inter J Gynecol Obstet,2001,75:251-255. 被引量：1
10G.Gioele,Andrea C,Guendalina L.,et al.MIB 1 Immunostaining in cervical carcinoma of young patients[J].Gynecol Oncol,1997,67:184-187. 被引量：1
